In this study, we observed a significant enhancement of anti-PD-1 treatment effect by DNase I. We hypothesized that DNase I may potentially eliminate tumor-induced NET formation to improve the PD-1 checkpoint inhibitor immunotherapies in colorectal cancer. This evidence concerns the gene PDCD1 and neoplasm.